U.S. begins first coronavirus clinical trial testing Gilead's experimental drug
U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc’s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
